Multi-Omics Integrative Analyses Identified Two Endotypes of Hip Osteoarthritis
- PMID: 39330487
- PMCID: PMC11434176
- DOI: 10.3390/metabo14090480
Multi-Omics Integrative Analyses Identified Two Endotypes of Hip Osteoarthritis
Abstract
(1) Background: Osteoarthritis (OA) is a heterogeneous disorder, and subgroup classification of OA remains elusive. The aim of our study was to identify endotypes of hip OA and investigate the altered pathways in the different endotypes. (2) Methods: Metabolomic profiling and genome-wide genotyping were performed on fasting blood. Transcriptomic profiling was performed on RNA extracted from cartilage samples. Machine learning methods were used to identify endotypes of hip OA. Pathway analysis was used to identify the altered pathways between hip endotypes and controls. GWAS was performed on each of the identified metabolites. Transcriptomic data was used to examine the expression levels of identified genes in cartilage. (3) Results: 180 hip OA patients and 120 OA-free controls were classified into three clusters based on metabolomic data. The combination of arginine, ornithine, and the average value of 7 lysophosphatidylcholines had an area under the curve (AUC) of 0.97 (95% CI: 0.96-0.99) to discriminate hip OA from controls, and the combination of γ-aminobutyric acid, spermine, aconitic acid, and succinic acid had an AUC of 0.96 (95% CI: 0.94-0.99) to distinguish two hip OA endotypes. GWAS identified 236 SNPs to be associated with identified metabolites at GWAS significance level. Pro-inflammatory cytokine levels were significantly different between two endotypes (all p < 0.05). (4) Conclusions: Hip OA could be classified into two distinct molecular endotypes. The primary differences between the two endotypes involve changes in pro-inflammatory factors and energy metabolism.
Keywords: endotypes; hip osteoarthritis; metabolomics.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Costello C.A., Hu T., Liu M., Zhang W., Furey A., Fan Z., Rahman P., Randell E.W., Zhai G. Metabolomics Signature for Non-Responders to Total Joint Replacement Surgery in Primary Osteoarthritis Patients: The Newfoundland Osteoarthritis Study. J. Orthop. Res. 2020;38:793–802. doi: 10.1002/jor.24529. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources